Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5439771b0e5363b99e40bca459d1dab |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-34 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 |
filingDate |
1990-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1992-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eeeeb4894b0df374bbde30e3ba314d7a |
publicationDate |
1992-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5082834-A |
titleOfInvention |
Anti-inflammatory and anti-ulcer compounds and process |
abstract |
Disclosed herein are anti-inflammatory and anti-ulcer copper coordination compounds and a process for using them in the treatment of arthritis and gastrointestinal ulcers in animal bodies. The copper coordination compounds utilized are the reaction products of copper salts with: 1. aromatic carboxylic acids or their alkaline earth salts; 2. heterocyclic carboxylic acids or their alkaline earth salts; 3. amino acids or their alkaline earth salts; 4. amines; and 5. suitably substituted steroids. The process disclosed comprises administering to experimental animals, orally or parentrally (subcutaneously), in controlled dosages, the aforementioned copper coordination compounds for the treatment of inflammation (i.e., arthritis) and ulcers of the gastrointestinal tract. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0942720-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002013275-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006084696-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004219223-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6734208-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8067022-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8097642-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6552072-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7511070-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007134314-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8158670-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005208200-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6491938-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005106210-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006089705-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006122690-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6306846-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6569441-B2 |
priorityDate |
1978-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |